Characterization of Extended-Spectrum β-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli from Posadas, Misiones, Argentina

References

• Bradford PA. Extended- spectrum 13-lactamases in the 21” Century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–951.
   PubMed Web of Science ®Google Scholar
• Nordmann P. Trends in 13-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998; 27: S100- S106.
   Google Scholar
• Paterson DL, Hujer KM, Hujer AM, Yesier B, Bonomo MD, Rice LB et al. Extended-spectrum 13-lactamases in Klebsiella pneumoniae bloodstream isolates from seven coun-tries: dominance and widespread prevalence of SHV- and CTX-M-type 13-lactamases. Antimicrob Agents Chemother 2003; 47 (11): 3554-3560.
   PubMed Web of Science ®Google Scholar
• Truppia LA, Mollerach A, Di Conza JA, Radice M, Mugna V, Mendez E et al. Comparaci6n de tres metodos microbiol6gicos para la detecci6n de betalactamasas de espec-tro extendido en enterobacterias aisladas en Santa Fe (Argentina). Enferm Infecc Microbiol Clin 2005; 23 (9): 525-528.
   PubMed Web of Science ®Google Scholar
• Quinteros M, Radice M, Gardella N, Rodriguez MM, Costa N, Kobernfeld E et al. Extended-spectrum 13-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hos-pitals. Antimicrob Agents Chemother 2003; 47 (9): 2864-2867.
   PubMed Web of Science ®Google Scholar
• Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1–14.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved Standard Ninth Edition M2-A9. Wayne, Pa. Clinical and Laboratory Standards Institute. 2007.
   Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard Seventh Edition M 7-A7, Wayne, Pa. Clinical and Laboratory Standards Institute. 2007.
   Google Scholar
• Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identifi-cation of 13-lactamases. J Gen Microbiol 1975; 88: 169–178
   PubMedGoogle Scholar
• Rossi, A, Lopardo H, Woloj M, Picandet AM, Maritio M, Galas M et al. Non-typhoid Salmonella spp resistant to cefotaxime. J Antimicrob Chemother 1995; 36: 697–702.
   PubMed Web of Science ®Google Scholar
• Birnboim HC, Doly J. A rapid alkaline extraction pro-cedure screening recombinant plasmid DNA. Nucleic Acid Res 1979; 7 (6): 1513–1523.
   PubMed Web of Science ®Google Scholar
• Turner PJ. Extended-Spectrum 13-Lactamases. Clin Infect Dis 2005; 41:S273- S275.
   Google Scholar
• Bantar C, Famiglietti A, Goldberg M. Three-year sur-veillance study of nosocomial bacterial resistance in Argentina. The Antimicrobial Committee; and the National Surveillance Program (SIR) Participants Group. Int J Infect Dis 2000; 4 (2): 85–90.
   Google Scholar
• Paterson DL, Bonomo RA. Extended-Spectrum 13-Lactamases: a Clinical Update. Clin Microbiol Rev 2005, 18 (4): 657–686.
   PubMed Web of Science ®Google Scholar
• Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302–307.
   PubMed Web of Science ®Google Scholar
• Casellas JM, Goldberg M. Incidence of strains produc-ing extended spectrum beta-lactamases in Argentina. Infection 1989; 17: 434–436.
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Casellas JM, Broger C, Stemplinger I. Novel plasmidic 13-lactamase in Salmonella typhimurium, abstr. C74, p. 90. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 1994.
   Google Scholar
• Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P et al. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 1992; 20: 158–163.
   PubMed Web of Science ®Google Scholar
• Power P, Radice M, Barberis C, De Mier C, Mollerach M, Maltagliatti M, et al. Cefotaxime-hydrolysing 13-lactamases in Morganella morganii. Eur J Clin Microbiol Infect Dis 1999; 18: 743–747.
   PubMed Web of Science ®Google Scholar
• Rodriguez C, Radice M, Perazzi B, Castro S, Juárez J, Santini P, et al. Resistencia enzimática a betalactámicos en el gênero Proteus y evaluaciem de los fenotipos y genotipos de resistencia a cefalosporinas de tercera y cuarta generaciem en Proteus mirabilis. Enferm Infecc Microbiol Clin 2005; 23 (3): 122–126.
   PubMed Web of Science ®Google Scholar
• Radice M, Gonzalez C, Power P, Vidal MC, Gutkind G. Third-generation cephalosporin resistance in Shigella son nei, Argentina. Emerg Infect Dis 2001; 7: 442–443.
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Grimm H, Schweighart S. A new plas-midic cefotaximase in a clinical isolate of Escherichia coll. Infection 1990; 18: 294–298.
   PubMed Web of Science ®Google Scholar
• Barthêlêmy M, Peduzzi J, Bernard H, Tancrède C, Labia R. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum 13-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta 1992; 1122: 15–22.
   PubMed Web of Science ®Google Scholar
• Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum 13-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002; 50: 393–396.
   PubMed Web of Science ®Google Scholar
• De Champs C, Chanal C, Sirot D, Baraduc R, Romaszko JP, Bonnet R, et al. Frequency and diversity of Class A extended-spectrum 13-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 2004; 54: 634–639.
   PubMed Web of Science ®Google Scholar
• Hernandez JR, Martinez-Martinez L, Cantôn R, Coque TM, Pascual A, and the Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum 13-lacta-mases in Spain. Antimicrob Agents Chemother 2005; 49: 2122–2125.
   Google Scholar
• Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perillim, Amicosante G, et al. CTX-M-Type extended-spectrum 13-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006; 50: 2700-2706.
   Google Scholar
• Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum 13-lacta-mases in UK. J Antimicrob Chemother2004; 54: 735–743.
   PubMed Web of Science ®Google Scholar
• Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, et al. PCR classification of CTX-M-type 13-Lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006; 50 (2): 791–795.
   PubMed Web of Science ®Google Scholar
• Radice M, Power P, Di Conza J, Gutkind G. Early dis-semination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002; 46: 602–604.
   PubMed Web of Science ®Google Scholar
• Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M-type) and bla(PER-2)13-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 2006; 57 (5): 975–978.
   PubMed Web of Science ®Google Scholar
• Bonnet R, Sampaio JLM, Labia R, De Champs C, Sirot D, Chanal C, Sirot J. A Novel CTX-M 13-lactamase (CTX-M-8) in Cefotaxime-resistant Enterobacteriaceae Isolated in Brazil. Antimicrob Agents Chemother 2000; 44 (7): 1936–1942.
   PubMed Web of Science ®Google Scholar
• Bonnet R, Dutor C, Sampaio JLM, Chanal C, Sirot D, Labia R, et al. Novel Cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-2403Gly. Antimicrob Agents Chemother 2001; 45 (8): 2269–2275.
   PubMed Web of Science ®Google Scholar
• Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, et al. Detection of CTX-M-type 13-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 2004; 48 (12): 4556–4561.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP, Colombian Nosocomial Resistance Study Group. Prevalence and characterization of extended-spectrum 13-lacta-mases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004; 49 (3): 217-22.
   PubMed Web of Science ®Google Scholar
• Torres L, Gagliotta V, Torres O, Benitez M, Dominguez M, Pedroza R. 13-lactamasas de espectro extendido en Enterobacterias aisladas en centros de Salud de Caracas. Rev Soc Ven Microbiol 2006; 26 (2): 80-88.
   Google Scholar
• Bello H, Trabal N, Ibátiez D, Reyes A, Dominguez M, Mella S, et al. 13-Lactamasas de familias diferentes a TEM y SHV en cepas de Klebsiella pneumoniae subespecie pneu-moniae aisladas en hospitales chilenos. Rev Med Chile 2005; 133: 737–739.
   PubMed Web of Science ®Google Scholar
• Villegas MV, Correa A, Perez F, Zuluaga T, Radice M, Gutkind G, et al. CTX-M-128-lactamase in a Klebsiella pneu-moniae clinical isolate in Colombia. Antimicrob Agents Chemother 2004; 48 (2): 629–631.
   PubMed Web of Science ®Google Scholar
• Power P, Di Conza J, Rodriguez MM, Ghiglione B, Ayala JA, Casellas JM, et al. Biochemical characterization of PER-2 and genetic environment of bla„R_2. Antimicrob Agents Chemother 2007; Apr 16; [Epub ahead of print].
   Google Scholar
• Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000; 45: 183–189.
   Google Scholar
• Brisse S, Milatovic D, Fluit AC, Verhoef J, Schmitz FJ. Epidemiology of quinolone resistance of Klebsiella pneumoni-ae and Klebsiella oxytoca in Europe. Eur J Clin Microbiol Infect Dis 2000; 19: 64–68.
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spec-trum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288–1294.
   PubMed Web of Science ®Google Scholar
• Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006; 34 (5 Suppl 1): 520–8; discussion S64-73.
   PubMed Web of Science ®Google Scholar